Global Coronary Artery Bypass Graft Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Coronary Artery Bypass Graft Market Insights, Forecast to 2034
Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
Market Analysis and InsightsGlobal Coronary Artery Bypass Graft Market
Global Coronary Artery Bypass Graft market is expected to reach to US$ 133.7 million in 2023, with a positive growth of %, compared with US$ 128.5 million in 2022. Backed with the increasing demand from downstream industries, Coronary Artery Bypass Graft industry is evaluated to reach US$ 164.3 million in 2033. The CAGR will be 3.5% during 2023 to 2033.
Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.
In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.
Report Covers
This report presents an overview of global Coronary Artery Bypass Graft market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Coronary Artery Bypass Graft market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Medtronic
TERUMO
Guidant
MAQUET
Vitalitec
Novadaq
KARL STORZ
Edwards Lifesciences
Genesee Biomedical
Sorin Group
Segment by Type
On-Pump CABG
Off-Pump CABG
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Coronary Artery Bypass Graft introduction, etc. Coronary Artery Bypass Graft Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Coronary Artery Bypass Graft
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Coronary Artery Bypass Graft Market
Global Coronary Artery Bypass Graft market is expected to reach to US$ 133.7 million in 2023, with a positive growth of %, compared with US$ 128.5 million in 2022. Backed with the increasing demand from downstream industries, Coronary Artery Bypass Graft industry is evaluated to reach US$ 164.3 million in 2033. The CAGR will be 3.5% during 2023 to 2033.
Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.
In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.
Report Covers
This report presents an overview of global Coronary Artery Bypass Graft market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Coronary Artery Bypass Graft market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Medtronic
TERUMO
Guidant
MAQUET
Vitalitec
Novadaq
KARL STORZ
Edwards Lifesciences
Genesee Biomedical
Sorin Group
Segment by Type
On-Pump CABG
Off-Pump CABG
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Coronary Artery Bypass Graft introduction, etc. Coronary Artery Bypass Graft Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Coronary Artery Bypass Graft
Chapter 13Methodology and Data Sources adopted by MRAResearch